Dlg4 and Vamp2 are involved in comorbid epilepsy and attention-deficit hyperactivity disorder: A microarray data
Xiao-Jun Xi1, Ji-Hong Tang2, Bing-Bing Zhang2
1Department of Neurology, Children's Hospital of Soochow University, Suzhou 215025, Jiangsu Province, China; Department of Pediatrics, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou 213000, Jiangsu Province, China.
Children with epilepsy have higher ADHD risk. This study identified Dlg4 and Vamp2 genes as key molecular factors potentially explaining the comorbidity between epilepsy and attention-deficit hyperactivity disorder (ADHD).
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Epilepsy in children is frequently comorbid with attention-deficit hyperactivity disorder (ADHD).
- This comorbidity negatively impacts quality of life.
- Understanding shared molecular mechanisms is crucial for effective treatment.
Purpose of the Study:
- To identify molecular mechanisms underlying the comorbidity of epilepsy and ADHD.
- To pinpoint shared genetic factors contributing to both conditions.
Main Methods:
- Utilized gene expression profiles from the Gene Expression Omnibus (GEO) database (GSE12457, GSE47752).
- Screened for differentially expressed genes (DEGs) in epilepsy and ADHD samples compared to controls.
- Applied Weighted Gene Coexpression Network Analysis (WGCNA) to identify relevant gene modules.
- Performed functional annotation and hub gene analysis.
Main Results:
- Identified three key modules associated with both epilepsy and ADHD.
- DEGs within these modules are implicated in synaptic vesicle cycle, neuronal regeneration, and neurotransmission.
- Dlg4 and Vamp2 were identified as common candidate genes in the pathogenesis of both disorders.
Conclusions:
- Dlg4 and Vamp2 may play significant roles in the comorbidity of epilepsy and ADHD.
- Further research into these genes could reveal novel therapeutic targets.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...


